Benztropine Mesylate
Overview
Benztropine mesylate is an anticholinergic agent used to reduce extrapyramidal side effects associated with neuroleptic treatments and in the management of Parkinson's disease. It works by blocking acetylcholine receptors, hence balancing neurotransmitters to alleviate symptoms.
API suppliers (3)
Suppliers of Benztropine Mesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 3 suppliers.
1 of 3 holds a GMP certificate on record in the EU or UK registers
- SIEGFRIED GRAFTON INC1 active DMF
- Fine Chemicals Corporation (PTY) Ltd.South Africa1 active DMF GMP on record
- Orion CorporationFinland
Therapeutic areas
Do you supply Benztropine Mesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.